Similar Posts
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…
Meetin an Agressive Go-To-Clinic Timeline
Download Full Case Study
Early Phase Development Using Integrated Solutions
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…
How to scale pharma manufacturing efficiently?
Pharmaceutical manufacturing is a complex journey. From the initial discovery of a potential drug to its eventual arrival in the hands of…
Pharma Prime™- Seamless Transition from Clinic to Market
Hycon’s Prime Pharma Solution offers the fastest route from clinical to commercial manufacturing. Through a proactive strategy, it evaluates production aspects in…
Mapping the Pathway to Designing Successful Treatments
Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase (phase 2 and beyond) are critical to the…
